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ABSTRACT
Objectives: 2D/3D transvaginal ultrasonography in evaluation of endometrium in postmenopausal women with abnormal 
uterine bleedings (AUB).
Material and methods: 2D/3D transvaginal ultrasonography (TVU) was performed in 118 menopausal women with AUB. 
Endometrial volume and thickness, uterine volume and endometrial vascularity were evaluated. Complete histologic 
evaluation of the endometrium was obtained through dilatation & curettage (D&C) and/or hysteroscopy. Accordingly, pa-
tients were divided into 3 groups: controls (no endometrial pathology, n = 49), GI (benign endometrial pathology, n = 37),  
GII (endometrial carcinoma, n = 32).
Results: GII had greater thickness and volume of the endometrium, compared to GI and controls. The presence of arterial 
vascular flow was identified only in GI and GII (51.35% and 93.75%, respectively). Endometrial volume merged together 
with uterine volume measurements (TVU-3D) showed a strong, statistical significance between GI and GII, allowing dif-
ferentiation of begin and malignant endometrial pathologies in postmenopausal women.
Conclusions: In TVU diagnostics of postmenopausal women with AUB the following play the most significant role:  
1) endometrial thickness (TVU-2D); 2) endometrial volume (TVU-3D); 3) uterine plus endometrial volume (TVU-3D); 4) vas-
cularization within the endometrium, allowing to differentiate between pathological and normal endometrium (TVU-2/3D). 
Evaluation of the endometrial vascularity, both in TVU-2D and TVU-3D technique, does not allow for reliable differentiation 
between benign lesions and endometrial cancer.
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INTRODUCTION
Evaluation of abnormal uterine bleeding or postmen-
opausal bleeding with ultrasonography imaging has, in 
recent years, become a routine, non-invasive procedure 
and an initial evaluation in patients with abnormal uter-
ine bleeding. This is especially enabled when transvaginal 
ultrasonography(TVU) became the standard examination 
in lieu of transabdominal ultrasonography. 
This technique allows for endometrial receptivity assess-
ment, which consists of description of endometrial pattern, 
endometrial thickness and/or endometrial volume [1].
TVU has also been used to qualitatively and quantita-
tively assess blood flow within the pelvic vessels and endo-
metrium through the application of pulsed-wave Doppler 
(both 2-D [2] and 3-D power Doppler (3-DPD) maps) [3].
And although TVU does not meet the criteria for 
screening, along with the improvement in the examina-
tion techniques-introduction of more sophisticated equip-
ment (including three-dimensional-3D devices) and skilled 
ultrasonographers — the diagnostic role of TUV in gynae-
cology is gaining an increasing importance and is not to 
be underestimated. 
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This is particularly important in postmenopausal wom-
en, where not only benign pathology of the endometrium 
(polyps, endometrial growths) but also an increased in-
cidence of neoplastic processes within the uterine cavity 
are observed. This relates primarily to Ca endometrii, the 
most common malignant neoplasm of the genital tract in 
women 50+ [4–6]. 
Ultrasound diagnostic of endometrial pathologies is 
particularly valuable not only in asymptomatic patients, 
where TVU evaluation would be the only indication for 
histopathological assessment (and possible diagnosis of the 
pathological process at an early stage of development), but 
also in women with symptoms of atypical spotting/bleed-
ing from the genital tract. In such cases, TVU is not only 
a standard part of the initial evaluations in the management 
of abnormal uterine bleeding, but also an important com-
ponent of the differential diagnosis, facilitating eligibility of 
patients to a particular type of approach: invasive, such as 
pipelle biopsy, dilatation & curettage (D&C), hysteroscopy 
or conservative.
MATERIAL AND METHODS
The study group consisted of 118 postmenopausal 
women (the absence of a period for one year), with abnor-
mal uterine bleedings (metrorrhagia post menopausam) 
hospitalized in the Department of Gynecology and Gy-
necological Oncology, Polish Mother’s Memorial Hospital 
— Research Institute (PMMH-RI), Lodz, Poland.
The study was carried out between 2012–2014 in the 
Department of Gynecology and Gynecologic Oncology as 
a statutory project number 2011/VI/5; and required an an-
nual, positive opinion of the PMMH-RI Scientific Council 
(PMMH-RI Ethical Committee approval was not required). 
An annual report had been submitted to the Department 
of Science PMMH-RI, as well as to the Ministry of Health 
— where the study was registered (ID number 192897).
Written informed consent was obtained from all patients. In 
all subjects a standard transvaginal ultrasound (TVU) in 2D 
(TVU-2D), combined with three-dimensional transvaginal 
evaluation (TVU-3D) of the endometrial and uterine volume 
was performed. TVU 2D/3D examination was performed 
using MEDISON ACCUVIX V10, with a three-dimensional 
5–9-MHz transvaginal transducer. Endometrial thickness 
in TVU-2D was measured via longitudinal sections of the 
endometrial echo (double layer). Whereas, in TVU-3D evalu-
ation a VOCAL technique (with 30° scan rotation) was used.
In each case, the presence of vascularization within 
the endometrium (Power Doppler) was verified, and the 
specific indices for 2D and 3D evaluations were measured 
— including pulsatility index (vPI), resistance index (vRI), 
systole/diastole ratio (v S/D), vascularization index (VI), flow 
index (FI) and vascularization flow index (VFI). Power Dop-
pler settings were set to achieve maximum sensitivity for 
detecting low-velocity flow without noise (e.g. frequency, 
5 MHz; power Doppler gain, 90; dynamic range, 70–90 dB; 
reject level, 2; colour map, type 2; frame average, 2; FSI, 1; 
density, low) (Fig. 1). 
Patients with fibroids of a diameter ≥ 20 mm found in 
TVU-2D, resulting in an increase in uterus volume, had been 
disqualified from participating in the study.
Following the TVU, a standard hysteroscopy and/or D&C 
was performed for complete histologic evaluation of the 
endometrium. 
Hysteroscopy was performed by experienced hyster-
oscopists, using a 5 mm rigid hysteroscope and local an-
aesthesia was used if required.
Eventually, women eligible for the study, were further 
subdivided into three groups, based on the results of the 
histological examination: the control group (no endometrial 
pathology, n = 49) and two study groups — GI (benign 
endometrial pathology-endometrial polypus, endometrial 
hyperplasia, n = 37) and G II (endometrial carcinoma, n = 32).
General characteristics of the study population, includ-
ing classic Ca endometrii risk factors (such as obesity, diabe-
tes, and arterial hypertension) are shown in Table 1.
Figure 1. Examples of endometrial 3D imaging with VOCAL 
technique
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The aim of this study was to assess the diagnostic ef-
ficiency of two-dimensional (2D) and three-dimensional 
(3D) transvaginal ultrasonography (TVS) in evaluating the 
endometrium of postmenopausal women with abnormal 
uterine bleedings.
Statistics
Statistical analysis was performed using Statistica 
12.0 software package and p < 0.05 was consider as in-
dicative of significant difference. U Mann-Whitney’s test and 
ANOVA Kruskal-Wallis’ test were performed in order to evalu-
ate the relationship between benign endometrial pathol-
ogy or endometrial cancer and the examined parameters 
(patient characteristics: e.g. age, BMI, menopause, other 
diseases and obesity) in the studied patients. The results of 
studied parameters are presented as median ± SEM and RQ 
means ± SD values. Statistica for Windows 10.0 program was 
applied for calculations considered as statistically significant. 
RESULTS
The results obtained in the TVU-2D/3D ultrasound evalu-
ations are shown in Table 2.
There was no statistically significant difference across the 
three groups of studied women for the parameter ‘uterine 
volume’. However, for the parameter ‘endometrial thickness’ 
statistically significant differences across the three studied 
groups were observed, as indicated in detail in Figures 2 and 3.
Moreover, for the parameter ‘endometrial volume’, there 
was also a statistically significant difference, especially when 
comparing groups GII and C (Fig. 4).
When evaluating the two parameters ‘uterine volume’ and 
‘endometrial volume’ in TVU-3D together, a strong statistical 
significance between group GI (benign endometrium pathol-
ogy) and GII (Ca endometrii) p < 0.0001 was observed (Fig. 5).
Vascular flow indices in both techniques: TVU-2D (PI, 
RI, S/D) and TVU-3D (VI, FI, VFI) showed no statistically sig-
nificant differences between groups GI and G II. However, 
Table 1. General characteristic of the study groups (mean values ± SD)
Characteristics C — normal endometrium (control group)
G I — benign 
endometrial pathology
G II — endometrial 
cancer P-value
Numbers 49 37 32
Mean age (years) 60.41 ± 10.86 64.77 ± 12.89 66.41 ± 7.95
P = 0.270
P* = 0.102
P** = 0.007
LMP (menopause) 
(years) 49.99 ± 3.61 51.75 ± 3.27 51.01 ± 4.24
P = 0.152
P* = 0.067
P** = 0.157
Menopausal age (years) 13.48 ± 12.56 16.10 ± 8.82 15.39 ± 9.41
P = 0.311
P* = 0.162
P** = 0.255
Arterial hypertension (%) 20 (40.81%) 16 (43.24%) 21 (65.62%)
P = 0.552
P* = 0.632
P** = 0.425
Diabetes (%) 5 (10.2%) 4 (10.81%) 10 (31.25%)
P = 0.285
P* = 0.219
P** = 0.112
Obesity (%) 13 (26.53%) 14 (37.83%) 18 (55.25%)
P = 0.635
P* = 0.523
P** = 0.327
BMI [kg/m2] 26.96 ± 4.66 29.42 ± 6.05 31.06 ± 7.07
P = 0.110
P* = 0.068
P** = 0.004
P* — between G I and C; P** — between G II and C
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Figure 2. Endometrial thickness among the three groups
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it should be noted that the presence of arterial flow within 
the endometrium was related to endometrial pathology 
(benign or malignant).
DISCUSSION
Vaginal bleeding in postmenopausal women is not 
unequivocal with a diagnosis of endometrial cancer. His-
topathological evaluation of the endometrium collected 
from women with AUB who participated in the current 
study showed that the largest group, representing 41.5% of 
the study population, were women with normal endome-
trium, 31.4% of them were characterized by the presence of 
benign endometrial pathology (hyperplasia + polyps) and 
27.1% were diagnosed with endometrial cancer. (However, 
the incidence of endometrial cancer in women with post-
menopausal bleeding seems to be atypically high due to 
the oncological profile of the department).
There are certain risk factors for endometrial cancer. 
In this study, analysis of the general characteristics of the 
study population confirmed the well-known fact, that the 
Ca endometrii is associated with the so-called Virchow’s 
triad; namely the presence of a higher incidence of arterial 
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Figure 3. Endometrial thickness between the groups GI or GII (benign 
endometrial pathology or Ca endometrii) and C (normal endometrium 
— control group)
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Figure 4. Endometrial volume between the two groups G II (Ca 
endometrii) and C (normal endometrium — control group)
Table 2. Ultrasound parameters in the study groups (mean values ± SD)
USG-2D/USG-3D examination C — normal endometrium (control group)
G I — benign endometrial 
pathology G II — endometrial cancer P-value
Uterine volume [cm3] 37.45 ± 36.18 38.77 ± 28.67 69.02 ± 45.86
P = 0.407
P* = 0.189
P** = 0.437
Endometrial thickness [mm] 4.74 ± 2.57 9.5 ± 5.45 18.69 ± 9.82 
P = 0.004
P* = 0.0002
P** = 0.00005
Endometrial volume [cm3] 2.08 ± 2.36 4.37 ± 4.23 17.89 ± 17.35
P = 0.00061
P* = 0.197
P** = 0.000007
Vascular flows (incl. arterial) 2.04% (0%) 54.05% (51.35%) 100% (93.75%)
P = 0.588
P* = 0.453
P** = 0.745
RI (–) 0.51 ± 0.09 0.43 ± 0.08 P*** = 0.355
PI (–) 0.74 ± 0.19 0.64 ± 0.17 P*** = 0.471
S/D (–) 2.10 ± 0.24 1.87 ± 0.28 P*** = 0.471
VI (–) 0.94 ± 1.36 2.61 ± 3.66 P*** = 0.098
FI (–) 26.89 ± 3.45 29.57 ± 4.59 P*** = 0.266
VFI (–) 0.18 ± 0.37 0.79 ± 1.19 P*** = 0.082
P* — between G I and C; P** — between G II a C; P*** — between GI and GII. In USG-3D technique uterine and endometrial volume were evaluated as well as VI, FI, VFI 
indices; the remaining parameters were evaluated in USG-2D technique (endometrial thickness, blood flow indices — PI, RI, S/D)
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hypertension, diabetes and obesity in a group of patients 
with Ca endometrii. The incidence of these in the patient 
group G II was 65.62%, 31.25% and 55.25% respectively. 
(It seems that the lack of statistical significance between 
the studied groups with regards to the aforementioned 
parameters was due to the relatively small sample num-
bers). Importantly in our study, women with Ca endometrii 
(GII) were the only group with obesity, with a mean BMI 
of 31.06 kg/m2 (a statistical significance between GII and 
the control group was observed; p = 0.004). Such data are 
consistent with the latest reports [7]. Women in GII group 
were also significantly older when compared to control 
group (an average of 6 years). 
In postmenopausal women the normal endometrium 
is thin (4–5 mm thickness) and characterized by a small 
volume of approximately 2 mL [8]. In our study, the aver-
age thickness of normal endometrium was 4.74 mm, with 
an average volume of 2.08 mL, which is consistent with data 
in the literature [8].
Endometrial cancer is characterized by a significant in-
crease in the thickness and volume of the endometrium [9], 
(here: over 13 mL). Measurement of the endometrium 
by means of TVU-2D and TVU-3D techniques, is a reliable 
diagnostic tool in women with postmenopausal AUB. In 
this study, using TVU-2D technique we demonstrated sta-
tistically significant differences across all three groups of 
women. We showed that depending on the endometrial 
pathology, endometrial thickness increased accordingly, 
from 4.7 mm (on average) in the control group to 9.5 mm 
in GI group (benign pathology) and to 18.69 mm in the GII 
(Ca endometrii). Using TVU-3D technique we demonstrated 
that the largest endometrial volume was observed in GII 
group (Ca endometrii), whereas the difference between GII-C 
groups reached a stronger statistical significance for TVU-3D 
(and endometrial volume) than for TVU-2D (and endome-
trial thickness). However, we did not notice a statistically 
significant difference between the control group and the 
GI group (benign endometrial pathology). 
Although the measurement of endometrial volume on its 
own was not able to distinguish between the studied groups 
GI and GII (lack of statistical significance, with higher volume 
in GII group), combining endometrial volume with uterus 
volume measurements appears to be an effective, comple-
mentary tool in the endometrial pathology evaluation.
Detection of vascular flow within the endometrium is 
a valuable component of the TVU 2D/3D examination. Avail-
able literature data from years 1991–2008 shows that the 
incidence of vascularization detected within the endome-
trium in patients with Ca endometrii varies within a wide 
range 40–90%, and in the case of endometrial hyperplasia 
is 4–6% [8, 10].
In the current study, endometrial vascularization was 
observed in 93.75% of women with endometrial cancer and 
in 51.35% of women with benign endometrial pathology 
(polyps + hyperplasia). The mere detection of arterial flow 
using power Doppler technique clearly demarcates the group 
of women with normal endometrium (here: lack of vasculari-
zation), from a group of women with benign or malignant en-
dometrial pathology (here: the presence of vascularization).
In our study, evaluation of vascular flow characteristics 
in both techniques TVU-2D and TVU-3D was of less impor-
tance. Although the average values of flow indices (VI, FI, VFI) 
in TVU-3D technique were higher, and in TVU-2D technique 
(PI, RI, S/D) lower in the GII group (Ca endometrii) when 
compared with GI group (benign endometrial pathology), 
the difference did not reach a statistical significance (the VFI 
parameter was the closest to reach statistical significance 
with p = 0.082). Therefore, in our study, assessment of en-
dometrium with pulsed-wave Doppler in 2D and 3D TVU 
did not enable distinction between benign and malignant 
endometrial pathology.
The results of this study are partly consistent with previ-
ous reports from Poland, where in women with endome-
trial hyperplasia or endometrial cancer, endometrium had 
been evaluated using TVU-2D/3D. This primarily concerns 
significantly higher values of the endometrium thickness 
and volume in the group with endometrial cancer when 
compared to the group with endometrial hyperplasia [11]. 
The researchers also found a significant correlation between 
the thickness of the endometrium and menopausal status, 
staging and grading of Ca endometrii (TVU-2D examina-
tion) [11]. This was not noticed for endometrial volume and 
the aforementioned parameters in TVU-3D technique [11]. 
Evaluation of blood flow indices within the endometrium in 
TVU-3D technique showed a statistically higher values for 
VI, FI, VFI in patients with endometrial cancer compared to 
Figure 5. The uterine volume and endometrial volume in groups GI 
and G II (benign and Ca endometrii), green squares and orange dots 
accordingly
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patients with hyperplasia (the same correlation has been 
demonstrated for menopausal status and staging) [11]. For 
the blood flow indices in TVU-2D (PI, RI, PSV), evaluated in 
the uterine artery, there were no statistically significant 
differences for groups with cancer and hyperplasia nor for 
menopausal status, staging and grading of this cancer (ex-
ception: lower PSV in postmenopausal women) [11]. 
In another, somewhat earlier report, it was demonstrat-
ed that in TVU-3D mean values of vascular indices VI, Fl and 
VFI in the group of women with endometrial cancer were 
respectively 5.46, 25.99 and 1.89 and were significantly 
higher in comparison to the other studied groups of women 
(with normal endometrium, hyperplasia) [12]. The values 
of vascular indices VI, Fl and VFI in our study using TVU-3D 
technique were similar (VI = 2.61, FI = 29.57, VFI = 0.79) and 
although they were higher than in the group with benign 
endometrial pathology, the values did not reach statistical 
significance.
In the current study we did not assess the depth of mus-
cle tissue infiltration by a neoplastic process, however in the 
available literature on TVU-3D examination a tumour-free 
distance to serosa (TDS) index is used with the cut-off value 
of 9 mm [13].
In general, measurement of the endometrium by means 
of TVU-2D and TVU-3D techniques is a reliable diagnostic 
tool in women with postmenopausal AUB.
Although not very popular in gynaecology, three-di-
mensional transvaginal examination (TVU-3D), when used 
to evaluate in particular endometrial volume and/or com-
bining the above parameter with uterine volume, seems to 
increase the accuracy of endometrium pathology diagnosis 
at the early stage. This, in turn, should have an impact on 
the choice of a particular therapeutic measure.
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